Since our data thus far indicated that TBL1 ablation may prevent glucose consumption in pancreatic cancer cells (Fig2C and D), we combined the “preventive” setup with the question whether TBL1 deficiency may also enhance chemosensitivity of pancreatic tumor cells. Here, TBL1Y is linked to pancreatic neoplasm.